Primary Immunodeficiency: Clinical Trials

1 trial for Primary Immunodeficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Primary Immunodeficiency: new trials by email Literature Review of Primary Immunodeficiency trials Research Report on Primary Immunodeficiency

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ASIS for GAMMAGARD in Primary Immunodeficiency
Gadolinium For abdomen, Gadolinium For lower back, Efficacy of Gammagard subcutaneously at Week 12 - Primary Immunodeficiency
Phase 1 / Phase 2UnknownASIS Corporation602016-01-012015-06-24

Narrower conditions

Primary Immunodeficiency Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)

Interventions

Gadolinium (1)  ·  Gadolinium DTPA (1)  ·  Immunoglobulins, Intravenous (1)

Sponsors

ASIS Corporation (1)

Countries

United States (1)

Top investigators

Hanh Nguyen, MD (1)  ·  Li Nguyen, MD (1)  ·  Thanh Phung, MD (1)